Delivery Order SPE2DB22D2007-SPE2DB24FJ5PS
Award Date
8/29/24
Potential Completion Date
8/30/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $7,369.92 and an ultimate completion date of December 5, 2024. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The contract, valued at $20,059.44, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes valued at $54,048.51. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price and is a delivery order, with a completion date of September 6, 2024. This contract is not set aside for any specific business category. Amerisourcebergen has been awarded numerous federal contracts, including...
This federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,656.26 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024, with a completion date of September 6, 2024. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp has been awarded numerous Indefinite Delivery...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $7,956.68, was granted on July 3, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 5, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $42,506.27, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside and appears to be part of a larger...
The federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $18,614.28 firm-fixed-price delivery order was awarded on May 24, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of May 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $14,751.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to federal agencies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The contract, valued at $26,745.93, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed price basis. The contract has a ceiling value of $6,715.70 and an ultimate completion date of April 25, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC)...